TABLE 2.
REDUCED expression | |||||
---|---|---|---|---|---|
Enzyme | Cancer | Cardiovascular | Metabolic | Neuronal | Refs |
Sod1−/− | ↑ | ↑ | ↑ | (47, 94, 96, 97) | |
Sod2+/− | ↑ | ↑ | ↑ | ↑ | (37, 64, 65, 67) |
Gpx1−/− | ↑ | ↑ | ↓ | ↓↑ | (40, 69–73) |
MsrA−/− | ↑ | ↑ | ↑ | (44, 74–78) | |
INCREASED expression | |||||
Sod1 TG | ↓ | ↓ | ↓ | (79–82) | |
Sod2 TG | - | ↓ | ↓ | ↓ | (53, 54, 80, 83–85) |
Gpx4 TG | ↓ | ↓ | (86, 87) | ||
Trx1 TG | ↑ | ↓ | ↓ | ↓ | (56, 88–93) |
mCAT TG | ↓ | ↓ | ↓ | ↓ | (98–103) |
↑ = increased incidence of pathology reported, ↓ = reduced incidence of pathology reported, ↓↑ = both increased and reduced incidence of pathology reported, - = no difference reported. Shaded boxes = no data published on pathological state for given model.